UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2018
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 001-37900
Everspin Technologies, Inc.
(Exact name of Registrant as specified in its Charter)
Delaware |
|
26-2640654 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
5670 W. Chandler Boulevard, Suite 100
Chandler, Arizona 85226
(Address of principal executive offices including zip code)
Registrant’s telephone number, including area code: (480) 347-1111
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). YES ☒ NO ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer |
☐ |
|
Accelerated filer |
☒ |
Non-accelerated filer |
☐ (Do not check if a small reporting company) |
|
Small reporting company |
☐ |
|
|
|
Emerging growth company |
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
☒ |
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☒
The number of shares of Registrant’s Common Stock outstanding as of May 2, 2018 was 16,673,683.
In this Quarterly Report on Form 10-Q, “we,” “our,” “us,” “Everspin Technologies,” and “the Company” refer to Everspin Technologies, Inc. The Everspin logo and other trade names, trademarks or service marks of Everspin Technologies are the property of Everspin Technologies, Inc. This report contains references to our trademarks and to trademarks belonging to other entities. Trade names, trademarks and service marks of other companies appearing in this report are the property of their respective holders. We do not intend our use or display of other companies’ trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
2
EVERSPIN TECHNOLOGIES, INC.
(In thousands, except share and per share amounts)
|
|
March 31, |
|
December 31, |
||
|
|
2018 |
|
2017 |
||
|
|
(Unaudited) |
|
(See Note 2) |
||
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
33,883 |
|
$ |
12,950 |
Accounts receivable, net |
|
|
8,904 |
|
|
3,429 |
Amounts due from related parties |
|
|
382 |
|
|
612 |
Inventory |
|
|
8,903 |
|
|
9,837 |
Prepaid expenses and other current assets |
|
|
1,207 |
|
|
590 |
Total current assets |
|
|
53,279 |
|
|
27,418 |
Property and equipment, net |
|
|
3,775 |
|
|
3,946 |
Other assets |
|
|
93 |
|
|
73 |
Total assets |
|
$ |
57,147 |
|
$ |
31,437 |
|
|
|
|
|
|
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Accounts payable |
|
$ |
2,337 |
|
$ |
2,720 |
Accrued liabilities |
|
|
2,127 |
|
|
2,254 |
Amounts due to related parties |
|
|
3,734 |
|
|
1,694 |
Deferred income on shipments to distributors |
|
|
— |
|
|
1,720 |
Current portion of long-term debt |
|
|
5,490 |
|
|
3,987 |
Total current liabilities |
|
|
13,688 |
|
|
12,375 |
Long-term debt, net of current portion |
|
|
6,772 |
|
|
8,178 |
Total liabilities |
|
|
20,460 |
|
|
20,553 |
Commitments and contingencies |
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of March 31, 2018 and December 31, 2017 |
|
|
— |
|
|
— |
Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 16,648,271 and 12,817,201 shares issued and outstanding as of March 31, 2018 and December 31, 2017 |
|
|
2 |
|
|
1 |
Additional paid-in capital |
|
|
154,201 |
|
|
128,422 |
Accumulated deficit |
|
|
(117,516) |
|
|
(117,539) |
Total stockholders’ equity |
|
|
36,687 |
|
|
10,884 |
Total liabilities and stockholders’ equity |
|
$ |
57,147 |
|
$ |
31,437 |
The accompanying notes are an integral part of these condensed financial statements.
3
EVERSPIN TECHNOLOGIES, INC.
Condensed Statements of Operations and Comprehensive Loss
(In thousands, except share and per share amounts)
(Unaudited)
|
|
Three Months Ended |
|
||||
|
|
March 31, |
|
||||
|
|
2018 |
|
2017 |
|
||
Product sales |
|
$ |
9,264 |
|
$ |
6,648 |
|
Product sales - related party |
|
|
101 |
|
|
— |
|
Licensing, royalty, and other revenue |
|
|
5,107 |
|
|
91 |
|
Licensing, royalty, and other revenue - related party |
|
|
381 |
|
|
1,141 |
|
Total revenue |
|
|
14,853 |
|
|
7,880 |
|
Cost of sales |
|
|
4,898 |
|
|
3,663 |
|
Gross profit |
|
|
9,955 |
|
|
4,217 |
|
Operating expenses: |
|
|
|
|
|
|
|
Research and development |
|
|
6,480 |
|
|
6,389 |
|
General and administrative |
|
|
3,219 |
|
|
2,845 |
|
Sales and marketing |
|
|
1,366 |
|
|
858 |
|
Total operating expenses |
|
|
11,065 |
|
|
10,092 |
|
Loss from operations |
|
|
(1,110) |
|
|
(5,875) |
|
Interest expense |
|
|
(211) |
|
|
(230) |
|
Other income, net |
|
|
44 |
|
|
19 |
|
Net loss and comprehensive loss |
|
$ |
(1,277) |
|
$ |
(6,086) |
|
Net loss per common share, basic and diluted |
|
$ |
(0.09) |
|
$ |
(0.49) |
|
Weighted-average shares used to compute net loss per common share, basic and diluted |
|
|
14,789,036 |
|
|
12,299,981 |
|
The accompanying notes are an integral part of these condensed financial statements.
4
EVERSPIN TECHNOLOGIES, INC.
Condensed Statement of Cash Flows
(In thousands)
(Unaudited)
|
|
Three Months Ended |
|
||||
|
|
March 31, |
|
||||
|
|
2018 |
|
2017 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,277) |
|
$ |
(6,086) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
373 |
|
|
232 |
|
Stock-based compensation |
|
|
625 |
|
|
431 |
|
Non-cash interest expense |
|
|
100 |
|
|
59 |
|
Compensation expense related to vesting of common stock to GLOBALFOUNDRIES |
|
|
237 |
|
|
255 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
Accounts receivable |
|
|
(5,810) |
|
|
513 |
|
Amounts due from related parties |
|
|
230 |
|
|
(37) |
|
Inventory |
|
|
888 |
|
|
(755) |
|
Prepaid expenses and other current assets |
|
|
(617) |
|
|
211 |
|
Other assets |
|
|
(20) |
|
|
(11) |
|
Accounts payable |
|
|
(353) |
|
|
695 |
|
Accrued liabilities |
|
|
(127) |
|
|
93 |
|
Amounts due to related parties |
|
|
2,052 |
|
|
717 |
|
Deferred income on shipments to distributors |
|
|
(39) |
|
|
(357) |
|
Net cash used in operating activities |
|
|
(3,738) |
|
|
(4,040) |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(244) |
|
|
(470) |
|
Net cash used in investing activities |
|
|
(244) |
|
|
(470) |
|
Cash flows from financing activities |
|
|
|
|
|
|
|
Proceeds from the issuance of common stock, net of offering costs |
|
|
24,609 |
|
|
— |
|
Payments on debt |
|
|
— |
|
|
(727) |
|
Payments on capital lease obligation |
|
|
(3) |
|
|
(7) |
|
Proceeds from exercise of stock options and purchase of shares in employee stock purchase plan |
|
|
309 |
|
|
9 |
|
Net cash provided by (used in) financing activities |
|
|
24,915 |
|
|
(725) |
|
Net increase (decrease) in cash and cash equivalents |
|
|
20,933 |
|
|
(5,235) |
|
Cash and cash equivalents at beginning of period |
|
|
12,950 |
|
|
29,727 |
|
Cash and cash equivalents at end of period |
|
$ |
33,883 |
|
$ |
24,492 |
|
Supplementary cash flow information: |
|
|
|
|
|
|
|
Interest paid |
|
$ |
111 |
|
$ |
171 |
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
Purchase of property and equipment in accounts payable and amounts due to related parties |
|
$ |
73 |
|
$ |
965 |
|
The accompanying notes are an integral part of these condensed financial statements.
5
EVERSPIN TECHNOLOGIES, INC.
Notes to Unaudited Condensed Financial Statements
1. Organization and Nature of Business
Everspin Technologies, Inc. (the Company) was incorporated in Delaware on May 16, 2008. The Company’s magnetoresistive (MRAM) solutions offer the persistence of non-volatile memory with the speed and endurance of random access memory (RAM) and enable the protection of mission critical data particularly in the event of power interruption or failure. The Company’s MRAM solutions allow its customers in the industrial, automotive and transportation, and enterprise storage markets to design high performance, power efficient and reliable systems without the need for bulky batteries or capacitors.
Ability to continue as a going concern
The Company believes that its existing cash and cash equivalents as of March 31, 2018, coupled with its anticipated growth and sales levels will be sufficient to meet its anticipated cash requirements for at least the next twelve months from the financial statement issuance date of May 9, 2018. The Company’s future capital requirements will depend on many factors, including its growth rate, the timing and extent of its spending to support research and development activities, the timing and cost of establishing additional sales and marketing capabilities, and the introduction of new products. The Company may be required at some point in the future to seek additional equity or debt financing, to sustain operations beyond that point, and such additional financing may not be available on acceptable terms or at all. If the Company is unable to raise additional capital or generate sufficient cash from operations to adequately fund its operations, it will need to curtail planned activities to reduce costs. Doing so will likely harm its ability to execute on its business plan.
2. Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2017 has been derived from the audited financial statements at that date but does not include all of the information required by GAAP for complete financial statements. These unaudited interim condensed financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair statement of the Company’s financial information. The results of operations for the three months ended March 31, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018 or for any other interim period or for any other future year.
The accompanying condensed financial statements and related financial information should be read in conjunction with the audited financial statements and the related notes thereto for the year ended December 31, 2017, included in the Company’s Annual Report on Form 10-K filed with the SEC.
Use of Estimates
The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, fair value of assets and liabilities, inventory, income taxes, and stock-based compensation. Actual results could differ from those estimates and assumptions.
6
Accounts receivable, net
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company generally does not require collateral or other security in support of accounts receivable. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables would be further adjusted. The Company also considers a number of factors in evaluating the sufficiency of its allowance for doubtful accounts, including the length of time receivables are past due, significant one-time events, creditworthiness of customers and historical experience. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. At March 31, 2018 and December 31, 2017, there was no allowance for doubtful accounts.
The Company also establishes an allowance for product returns. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of products when evaluating the adequacy of sales returns. As the returns are processed as credits on future purchases, the allowance is recorded against the balance of trade accounts receivable. In addition, the Company establishes an allowance for estimated price concessions related to its distributer agreements. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales or, for some customers the credit is based on a previously negotiated fixed rate. At March 31, 2018, the allowance for product returns and the allowance for price concessions were $173,000 and $399,000, respectively. At December 31, 2017, the allowance for product returns and the allowance for price concessions were $147,000 and $0, respectively.
Accounts receivable, net consisted of the following (in thousands):
|
|
March 31, |
|
December 31, |
||
|
|
2018 |
|
2017 |
||
Trade accounts receivable |
|
$ |
9,440 |
|
$ |
3,576 |
Allowance for accounts receivable |
|
|
(572) |
|
|
(147) |
Unbilled accounts receivable |
|
|
36 |
|
|
— |
Accounts receivable, net |
|
$ |
8,904 |
|
$ |
3,429 |
Concentration of Credit Risk
Financial instruments that potentially expose the Company to a concentration of credit risk consist principally of cash and cash equivalents that are held by a financial institution in the United States and accounts receivable. Amounts on deposit with a financial institution may at times exceed federally insured limits. The Company maintains its cash accounts with high credit quality financial institutions and, accordingly, minimal credit risk exists with respect to the financial institutions.
Significant customers are those which represent more than 10% of the Company’s total revenue or net accounts receivable balance at each respective balance sheet date. For the purposes of this disclosure, the Company defines “customer” as the entity that is purchasing the products or licenses directly from the Company, which includes the distributors of the Company’s products in addition to end customers that the Company sells to directly. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:
|
|
Revenue |
|
Accounts Receivable, net |
|
|
||||
|
|
Three Months Ended |
|
As of |
|
As of |
|
|
||
|
|
March 31, |
|
March 31, |
|
December 31, |
|
|
||
Customers |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
|
|
Customer A |
|
34 |
% |
* |
|
54 |
% |
* |
|
|
Customer B |
|
13 |
|
10 |
% |
* |
|
* |
|
|
Customer C |
|
* |
|
18 |
% |
* |
|
* |
|
|
Customer D |
|
* |
|
* |
|
* |
|
15 |
% |
|
Customer E |
|
* |
|
13 |
% |
* |
|
10 |
% |
|
*Less than 10%
7
Fair Value of Financial Instruments
The Company discloses and recognizes the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). The guidance establishes three levels of the fair value hierarchy as follows:
Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.
Level 2—Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.
Level 3—Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
The carrying value of accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. As of March 31, 2018, based on Level 2 inputs and the borrowing rates available to the Company for loans with similar terms and consideration of the Company’s credit risk, the carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value. The Company’s financial instruments consist of Level 1 assets. Where quoted prices are available in an active market, securities are classified as Level 1. Level 1 assets consist of highly liquid money market funds that are included in cash equivalents.
The following table sets forth the fair value of the Company’s financial assets measured at fair value on a recurring basis based on the three-tier fair value hierarchy (in thousands):
|
|
March 31, 2018 |
||||||||||
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
|
Total |
|||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
34,408 |
|
$ |
— |
|
$ |
— |
|
$ |
34,408 |
Total assets measured at fair value |
|
$ |
34,408 |
|
$ |
— |
|
$ |
— |
|
$ |
34,408 |
|
|
December 31, 2017 |
||||||||||
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
|
Total |
|||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
13,369 |
|
$ |
— |
|
$ |
— |
|
$ |
13,369 |
Total assets measured at fair value |
|
$ |
13,369 |
|
$ |
— |
|
$ |
— |
|
$ |
13,369 |
Revenue Recognition
The Company recognizes revenue when a customer obtains control of the promised products or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and price concessions, and any taxes collected from customers, which are subsequently remitted to governmental authorities.
Nature of Products and Services
The Company’s revenue is derived from the sale of MRAM-based products in discrete unit form, licenses of and royalties on its MRAM and magnetic sensor technology, the sale of backend foundry services and design services to third parties. Sales of products in discrete unit form are recognized at a point in time, revenue related to licensing agreements is recognized when the Company has delivered rights to the technology, revenue related to royalty
8
agreements is recognized in the period in which sales generated from products sold using the Company’s technology occurs, and sales of backend foundry services and design services to third parties are recognized over time.
Product Revenue
For products sold in their discrete form, the Company either sells its products directly to original equipment manufacturers (OEMs), original design manufacturers (ODMs) and contract manufacturers (CMs), or through a network of distributors, who in turn sell to those customers. For sales directly to OEMs, ODMs and CMs, revenue is recognized when the OEM, ODM or CM obtains control of the product, which occurs at a point in time, generally upon shipment to the customer.
The Company sells the majority of its products to its distributors at a uniform list price. However, distributors may resell the Company’s products to end customers at a very broad range of individually negotiated price points. Distributors are provided with price concessions subsequent to the delivery of product to them and such amounts are dependent on the end customer and product sales price. The price concessions are based on a variety of factors, including customer, product, quantity, geography and competitive differentiation. Price protection rights grant distributors the right to a credit in the event of declines in the price of the Company’s products. Under these circumstances, the Company remits back to the distributor a portion of their original purchase price after the resale transaction is completed in the form of a credit against the distributors’ outstanding accounts receivable balance. The credits are on a per unit basis and are not given to the distributor until the distributor provides information regarding the sale to their end customer. The Company estimates these credits and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of an allowance for price concessions due to distributors. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales or, for some customers the credit is based on a previously negotiated fixed rate. Revenue on shipments to distributors is recorded when control of the products has been transferred to the distributor.
The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company estimates its product return liability by analyzing its historical returns, current economic trends and changes in customer demand and acceptance of products. The Company has received insignificant returns to date and believes that returns of its products will continue to be minimal. As such, the Company does not record any reserve for returns but will continue to evaluate the need for a reserve each reporting period.
At the time of shipment to distributors, the Company records a trade receivable for the selling price as there is a legally enforceable obligation of the distributor to pay for the product delivered, an allowance is recorded for the estimated discount that will be provided to the distributor, and the net of these amounts is recorded as revenue on the statement of operations.
License Revenue
For licenses of technology, recognition of revenue is dependent upon whether the Company has delivered rights to the technology, and whether there are future performance obligations under the contract. In some instances, the license agreements call for future events or activities to occur in order for milestones amounts to become due from the customer. The terms of such agreements include payment to the Company of one or more of the following: non-refundable upfront fees; and royalties on net sales of licensed products. Historically, these license agreements have not included other future performance obligations for the Company once the license has been transferred to the customer.
The transaction price in each agreement is allocated to the identified performance obligations based on the standalone selling price (SSP) of each distinct performance obligation. Judgment is required to determine SSP. In instances where SSP is not directly observable, such as when a license or service is not sold separately, SSP is determined using information that may include market conditions and other observable inputs.
Revenue from non-refundable up-front payments is recognized when the license is transferred to the customer and the Company has no other performance obligations.
9
Royalties
Revenue from sales-based royalties from licenses of the Company’s technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part).
Other Revenue
For certain revenue streams, the Company recognizes revenue based on the pattern of transfer of the services. The Company uses the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract as this method most faithfully depicts its performance. The Company will record an unbilled receivable (within accounts receivable, net) for the portion of the work that has been completed but not invoiced at the end of each reporting period.
Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. At the inception of each agreement that includes milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price by using the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. At the end of each subsequent reporting period, the Company re-evaluates the probability or achievement of each such milestone and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.
Net Loss per Common Share
Basic net loss per common share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period, less shares subject to repurchase, without consideration of potentially dilutive securities. Diluted net loss per common share is the same as basic net loss per common share since the effect of potentially dilutive securities is anti-dilutive.
Prior Period Reclassifications
Certain amounts in the prior period have been reclassified to conform with current period presentation. There was no impact on total revenue or net loss for the prior period.
Recently Adopted Pronouncements
ASU No. 2014-09, Revenue from Contracts with Customers
In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606). Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. The new standard permits adoption either by using (i) a full retrospective approach for all periods presented in the period of adoption or (ii) a modified retrospective approach with the cumulative effect of initially applying the new standard recognized at the date of initial application and providing certain additional disclosures. The new standard is effective for annual reporting periods beginning after December 15, 2017. The Company adopted this standard on January 1, 2018 using the modified retrospective method. The Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of its accumulated deficit. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods.
As a result of the adoption of the new standard, the Company changed its accounting policy for revenue recognition and the details of the significant changes and quantitative impact of the changes are disclosed below.
Distributor sales - Some of the Company's contracts with distributors provide the distributor with certain concessions and price protection credits. Under Topic 605, Revenue, these concessions and price protection credits were not fixed or determinable and, as a result, the associated revenue was deferred until delivery of the product to
10
the end customer. At the time of shipment to distributors, the Company recorded a trade receivable for the selling price as there was a legally enforceable obligation of the distributor to pay for the product delivered, inventory was reduced by the carrying value of goods shipped, and the net of these amounts, the gross profit, was recorded as deferred income on shipments to distributors on the balance sheet. Under Topic 606, the Company recognizes revenue from sales to distributors upon delivery of the product to the distributor and estimates the amount of the concessions and price protection credits at the point of revenue recognition. Accordingly, the balance of the deferred income on shipments was eliminated as a cumulative effect adjustment of implementing Topic 606 as of January 1, 2018, net of the Company’s estimate of concessions and price protection credits for those contracts.
Performance obligations delivered over time –Topic 605 permitted straight-line recognition of revenue for performance obligations that were delivered over time. The new revenue standard requires an entity to recognize revenue based on the pattern of transfer of the services. Entities must use either an input method or an output method to measure progress toward complete satisfaction of a performance obligation. The Company determined that the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract most faithfully depicts its performance. Under Topic 606, the Company will record an unbilled receivable (within accounts receivable, net) for the portion of the service that has been completed but not invoiced at the end of each reporting period.
Milestone payments – Topic 605 permitted recognition using the milestone method, whereby revenue was recognized upon the completion of substantive milestones once the customers acknowledge the milestones have been met and the collection of the amounts is reasonably assured. The milestone method no longer exists under the new revenue standard. Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. The adoption of Topic 606 did not have an impact on milestone revenue recorded to date as the performance obligations related to such milestones were as of the adoption date.
Sales-based royalties – Topic 605 permitted recognition of royalties when reported to the Company, which generally coincided with the receipt of payment. Under the new revenue standard, revenue generated from sales-based royalties from licenses of technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part).
The change in revenue recognition upon adoption of Topic 606 resulted in a decrease in the accumulated deficit balance of $1.3 million on January 1, 2018.
The following table summarizes the impact of adopting Topic 606 on select unaudited condensed balance sheet line items (in thousands):
|
|
|
|
|
|
Balances without |
|||
|
|
|
|
|
|
the adoption of |
|||
March 31, 2018 |
|
As reported |
|
Adjustments |
|
Topic 606 |
|||
Accounts receivable, net |
|
$ |
8,904 |
|
$ |
363 |
|
$ |
9,267 |
Inventory |
|
|
8,903 |
|
|
26 |
|
|
8,929 |
Total current assets |
|
|
53,279 |
|
|
389 |
|
|
53,668 |
Total assets |
|
|
57,147 |
|
|
389 |
|
|
57,536 |
Deferred income on shipments to distributors |
|
|
— |
|
|
2,197 |
|
|
2,197 |
Total current liabilities |
|
|
13,688 |
|
|
2,197 |
|
|
15,885 |
Total liabilities |
|
|
20,460 |
|
|
2,197 |
|
|
22,657 |
Accumulated deficit |
|
|
(117,516) |
|
|
(1,808) |
|
|
(119,324) |
Total liabilities and stockholders’ equity |
|
|
57,147 |
|
|
389 |
|
|
57,536 |
11
The following table summarizes the impact of adopting Topic 606 on select unaudited condensed statement of operations line items (in thousands, except per share data):
|
|
|
|
|
|
Balances without |
|||
|
|
|
|
|
|
the adoption of |
|||
Three Months Ended March 31, 2018 |
|
As reported |
|
Adjustments |
|
Topic 606 |
|||
Product sales |
|
$ |
9,365 |
|
$ |
(831) |
|
$ |
8,534 |
Licensing, royalty, and other revenue |
|
|
5,488 |
|
|
29 |
|
|
5,517 |
Total revenue |
|
|
14,853 |
|
|
(802) |
|
|
14,051 |
Cost of sales |
|
|
4,898 |
|
|
(294) |
|
|
4,604 |
Gross profit |
|
|
9,955 |
|
|
(508) |
|
|
9,447 |
Loss from operations |
|
|
(1,110) |
|
|
(508) |
|
|
(1,618) |
Net loss and comprehensive loss |
|
|
(1,277) |
|
|
(508) |
|
|
(1,785) |
Net loss per common share, basic and diluted |
|
|
(0.09) |
|
|
(0.03) |
|
|
(0.12) |
The following table summarizes the impact of adopting Topic 606 on select unaudited condensed statement of cash flows line items (in thousands):
|
|
|
|
|
|
Balances without |
|||
|
|
|
|
|
|
the adoption of |
|||
Three Months Ended March 31, 2018 |
|
As reported |
|
Adjustments |
|
Topic 606 |
|||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,277) |
|
$ |
(508) |
|
$ |
(1,785) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(5,810) |
|
|
(28) |
|
|
(5,838) |
Inventory |
|
|
888 |
|
|
20 |
|
|
908 |
Deferred income on shipments to distributors |
|
|
(39) |
|
|
516 |
|
|
477 |
ASU No. 2017-09, Compensation-Stock Compensation
In May 2017, the FASB issued ASU No. 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting, which is intended to amend the scope of modification accounting for share-based payment arrangements. The amendments in the update provide guidance on types of changes to the terms or conditions of share-based payment awards that would require the Company to apply modification accounting under ASC 718, Compensation-Stock Compensation. This ASU is effective for annual reporting periods beginning after December 15, 2017, and early adoption was permitted. The Company adopted this standard on January 1, 2018, and the impact of its adoption on the Company’s financial statements was not material.
ASU No. 2016-15, Statement of Cash Flows
In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows. The standard is effective for fiscal years and interim periods beginning after December 15, 2017. The standard should be applied retrospectively and early adoption was permitted, including adoption in an interim period. The Company adopted this standard on January 1, 2018, and the impact of its adoption on the Company’s financial statements was not material.
12
3. Revenue
Adoption of ASU No. 2014-09
On January 1, 2018, the Company adopted ASU No. 2014-09 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605.
The Company sells the majority of its products to its distributors, but does recognize some revenue under licensing and royalty agreements. The following table presents the Company’s revenues disaggregated by sales channel, (in thousands):
|
Three Months Ended |
|
|
March 31, 2018 |
|
Distributor |
$ |
8,145 |
Non-distributor |
|
6,708 |
Total revenue |
$ |
14,853 |
All of the Company's performance obligations and associated revenue are generally transferred to customers at a point in time, with the exception of certain revenue streams which are performed over time commensurate with the delivery of service. The following table presents the Company’s revenues disaggregated by timing of recognition (in thousands):
|
Three Months Ended |
|
|
March 31, 2018 |
|
Point in time |
$ |
14,472 |
Over time |
|
381 |
Total revenue |
$ |
14,853 |
The following table presents the Company’s revenues disaggregated by type (in thousands):
|
Three Months Ended |
|
|
March 31, 2018 |
|
Product sales |
$ |
9,365 |
License fees |
|
5,000 |
Royalties |
|
107 |
Other revenue |
|
381 |
Total revenue |
$ |
14,853 |
The Company recognizes revenue in three primary geographic regions: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific and Japan (APJ). The following table presents the Company’s revenues disaggregated by the geographic region to which the product is delivered or licensee is located (in thousands):
|
Three Months Ended |
|
|
March 31, 2018 |
|
North America |
$ |
1,731 |
EMEA |
|
3,051 |
APJ |
|
10,071 |
Total revenue |
$ |
14,853 |
13
4. Balance Sheet Components
Inventory
Inventory consisted of the following (in thousands):
|
|
March 31, |
|
December 31, |
||
|
|
2018 |
|
2017 |
||
Raw materials |
|
$ |
— |
|
$ |
682 |
Work-in-process |
|
|
4,928 |
|
|
4,517 |
Finished goods |
|
|
3,975 |
|
|
4,638 |
Total inventory |
|
$ |
8,903 |
|
$ |
9,837 |
Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
|
|
March 31, |
|
December 31, |
||
|
|
2018 |
|
2017 |
||
Accrued payroll-related expenses |
|
$ |
1,142 |
|
$ |
1,331 |
Accrued inventory |
|
|
183 |
|
|
524 |
Deferred rent |
|
|
284 |
|
|
230 |
Accrued sales commissions payable to sales representatives |
|
|
92 |
|
|
75 |
Other |
|
|
426 |
|
|
94 |
Total accrued liabilities |
|
$ |
2,127 |
|
$ |
2,254 |
5. Debt
2017 Credit Facility
On May 4, 2017, the Company entered into a Loan and Security Agreement with Silicon Valley Bank (2017 Credit Facility) for a $12.0 million term loan. The term loan provides for interest at a floating rate equal to the prime rate minus 0.75%. As of March 31, 2018, the interest rate was 4.00%. The term loan provides for a period of interest-only payments through April 30, 2018, followed by fixed principal and interest payments based on either a 24-month amortization schedule or a 36-month amortization schedule if the Company meets certain sales milestones. As of December 31, 2017, the Company determined it would not meet the sales milestones and as such the term loan will be based on a 24-month amortization schedule. Borrowings under the 2017 Credit Facility mature in May 2020. The Company is required to comply with certain covenants under the 2017 Credit Facility, including requirements to maintain a minimum liquidity ratio, meet certain revenue targets, and restrictions on certain actions without the consent of the lender, such as the disposal and acquisition of its business or property, changes in business, and mergers or acquisitions. An end of term fee of 6% of the amount borrowed must be made when the loan is prepaid or repaid, whether at maturity or as a result of a prepayment or acceleration or otherwise. The additional payment is being accreted using the effective interest method.
Security for the 2017 Credit Facility includes all of the Company’s assets except for intellectual property. The 2017 Credit Facility contains customary covenants restricting the Company’s activities, including limitations on its ability to sell assets, engage in mergers and acquisitions, enter into transactions involving related parties, incur indebtedness or grant liens or negative pledges on its assets, make loans or make other investments. Under these covenants, the Company is prohibited from paying cash dividends with respect to its capital stock. The Company was in compliance with all covenants at March 31, 2018. The 2017 Credit Facility contains a material adverse effect clause which provides that an event of default will occur if, among other triggers, an event occurs that could reasonably be expected to result in a material adverse effect on the Company’s business, operations or condition, or on the Company’s ability to perform its obligations under the term loan. As of March 31, 2018, management does not believe that it is probable that the clause will be triggered within the next twelve months, and therefore the term loan is classified as long-term.
14
The carrying value of the Company’s 2017 Credit Facility at March 31, 2018 was as follows (in thousands):
|
|
Current |
|
Long-Term |
|
|
|
||
|
|
Portion |
|
Debt |
|
Total |
|||
Debt, including end of term fee |
|
$ |
5,500 |
|
$ |
7,220 |
|
$ |
12,720 |
Less: |
|
|
|
|
|
|
|
|
|
Discount attributable to end of term fee and debt issuance costs |
|
|
(20) |
|
|
(465) |
|
|
(485) |
Net carrying value of debt |
|
$ |
5,480 |
|
$ |
6,755 |
|
$ |
12,235 |
The carrying value of the Company’s 2017 Credit Facility at December 31, 2017 was as follows (in thousands):
|
|
Current |
|
Long-Term |
|
|
|
||
|
|
Portion |
|
Debt |
|
Total |
|||
Debt, including end of term fee |
|
$ |
4,000 |
|
$ |
8,720 |
|
$ |
12,720 |
Less: |
|
|
|
|
|
|
|
|
|
Discount attributable to end of term fee and debt issuance costs |
|
|
(23) |
|
|
(563) |
|
|
(586) |
Net carrying value of debt |
|
$ |
3,977 |
|
$ |
8,157 |
|
$ |
12,134 |
Capital Lease Obligations
The Company leases certain equipment under a capital lease obligation expiring in October 2020. The balance of the capital lease obligation was $27,000 and $31,000 at March 31, 2018 and December 31, 2017, respectively.
Property and equipment under the capital lease amounted to $31,000 at March 31, 2018 and December 31, 2017. Accumulated depreciation and amortization on these assets was $5,000 and $2,000 at March 31, 2018 and December 31, 2017, respectively.
6. Stockholders’ Equity
In February 2018, the Company completed a follow-on underwritten public offering of its common stock under its Registration Statement filed in November 2017 (File No. 333-221331), selling 3,772,447 shares of its common stock at an offering price of $7.00 per share for proceeds of $24.6 million, net of $1.8 million of underwriting discounts and commissions and other offering costs.
15
7. Stock-Based Compensation
The following table summarizes the stock option activity for the three months ended March 31, 2018:
|
|
|
|
Options Outstanding |
||||||||
|
|
|
|
|
|
Weighted- |
|
Weighted- |
|
|
|
|
|
|
|
|
|
|
Average |
|
Average |
|
|
|
|
|
|
Options |
|
|
|
Exercise |
|
Remaining |
|
Aggregate |
||
|
|
Available for |
|
Number of |
|
Price Per |
|
Contractual |
|
Intrinsic |
||
|
|
Grant |
|
Options |
|
Share |
|
Life (years) |
|
Value |
||
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
Balance—December 31, 2017 |
|
83,929 |
|
1,593,195 |
|
$ |
8.88 |
|
6.6 |
|
$ |
1,997 |
Prior period adjustment |
|
(1,026) |
|
13,784 |
|
|
4.54 |
|
0.3 |
|
|
|
Options authorized |
|
384,516 |
|
— |
|
|
|
|
|
|
|
|
RSUs granted |
|
(36,350) |
|
— |
|
|
|
|
|
|
|
|
RSUs cancelled/forfeited |
|
400 |
|
— |
|
|
|
|
|
|
|
|
Options granted |
|
(218,600) |
|
218,600 |
|
|
9.12 |
|
|
|
|
|
Options exercised |
|
— |
|
(58,229) |
|
|
5.31 |
|
|
|
$ |
200 |
Options cancelled/forfeited |
|
— |
|
(391) |
|
|
6.63 |
|
|
|
|
|
Balance—March 31, 2018 |
|
212,869 |
|
1,766,959 |
|
$ |
7.04 |
|
7.0 |
|
$ |
1,949 |
Options exercisable—March 31, 2018 |
|
|
|
783,554 |
|
$ |
5.29 |
|
4.0 |
|
$ |
1,803 |
The total grant date fair value of options vested was $377,000 and $107,000 during the three months ended March 31, 2018 and 2017, respectively.
The weighted-average grant date fair value of employee options granted during the three months ended March 31, 2018 and 2017 was $4.74 and $3.69 per share, respectively.
2016 Employee Stock Purchase Plan
In January 2018, there was an increase of 128,172 shares reserved for issuance under the Company’s Employee Stock Purchase Plan (ESPP).
Modification of Stock Awards
In February 2018, the Company modified the terms of 400,000 vested and unvested stock option awards granted to the Chief Executive Officer, by reducing their exercise price from $16.25 per share to $7.64 per share. There was no change to any of the other terms of the option awards. The modification resulted in an incremental value of $600,000 being allocated to the options, of which $63,000 was recognized to expense immediately based on options that were vested at the time of the modification. The remaining incremental value of $537,000 attributable to unvested options will be recognized over the remaining vesting term through September 2021.
16
Restricted Stock Units
The following table summarizes Restricted Stock Units (RSUs) activity for the three months ended March 31, 2018:
|
|
RSUs Outstanding |
|||
|
|
|
|
Weighted- |
|
|
|
|
|
Average |
|
|
|
Number of |
|
Grant Date |
|
|
|
Restricted Stock |
|
Fair Value Per |
|
|
|
Units |
|
Share |
|
Balance—December 31, 2017 |
|
30,680 |
|
$ |
10.55 |
Granted |
|
36,350 |
|
|
9.12 |
Cancelled/forfeited |
|
(400) |
|
|
7.80 |
Balance—March 31, 2018 |
|
66,630 |
|
$ |
9.79 |
The fair value of RSUs is determined on the date of grant based on the market price of the Company’s common stock on that date. As of March 31, 2018, there was $535,000 of unrecognized stock-based compensation expense related to RSUs to be recognized over a weighted-average period of 3.4 years.
Stock-based Compensation Expense
The Company recognized stock-based compensation expense from awards granted to employees and non-employees under its equity incentive plans and from its ESPP as follows, excluding amounts related to GLOBALFOUNDRIES, Inc. (GF) (in thousands):
|
|
Three Months Ended |
|
||||
|
|
March 31, |
|
||||
|
|
2018 |
|
2017 |
|
||
Research and development |
|
$ |
108 |
|
$ |
172 |
|
General and administrative |
|
|
433 |
|
|
226 |
|
Sales and marketing |
|
|
84 |
|
|
33 |
|
Total |
|
$ |
625 |
|
$ |
431 |
|
As of March 31, 2018, there was $6.2 million of total unrecognized compensation expense related to unvested options which is expected to be recognized over a weighted-average period of 3.3 years.
Employee Stock-based Compensation
Stock-based compensation expense for employees was $610,000 and $420,000 for the three months ended March 31, 2018 and 2017, respectively.
The Company estimated the fair value of each option using the Black-Scholes option-pricing model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee stock options was estimated using the assumptions below. Each of these inputs is subjective and its determination generally requires significant judgment.
|
|
Option Plan |
|
ESPP |
|
|
||||
|
|
Three Months Ended |
|
Three Months Ended |
|
|
||||
|
|
March 31, |
|
March 31, |
|
|
||||
|
|
2018 |
|
2017 |
|
2018 |
|
2017 |
|
|
Expected volatility |
|
51.9-52.0 |
% |
47.2-47.3 |
% |
66.2-72.7 |
% |
— |
% |
|
Risk-free interest rate |
|
2.70-2.72 |
% |
2.0-2.1 |
% |
0.94 |
% |
— |
% |
|
Expected term (in years) |
|
6.08 |
|
5.8-6.0 |
|
0.5 |
|
— |
|
|
Dividend yield |
|
— |
% |
— |
% |
— |
% |
— |
% |
|
Non-employee Stock-based Compensation
Stock-based compensation expense related to stock options granted to non-employees is recognized as the stock options vest. During the three months ended March 31, 2018, the Company granted 7,200 stock options to non-
17
employees. No stock options were granted to non-employees during the three months March 31, 2017. As of March 31, 2018, options to purchase 45,072 shares of common stock were outstanding with a weighted-average exercise price of $9.15 per share. Stock-based compensation expense for non-employees was $15,000 and $11,000 for the three months ended March 31, 2018 and 2017, respectively.
8. Related Party Transactions
Joint Development Agreement—GLOBALFOUNDRIES
On October 17, 2014, the Company entered into a Joint Development Agreement (JDA) with GF, a related party due to its equity ownership in the Company, for the joint development of the Company’s Spin Transfer Torque MRAM (STT-MRAM) technology. The term of the agreement is the later of four years from the effective date or until the completion, termination or expiration of the last statement of work entered into pursuant to the JDA. The JDA also states that the specific terms and conditions for the production and supply of the developed STT-MRAM technology would be pursuant to a separate manufacturing agreement entered into between the parties.
Under the JDA, each party licenses its relevant intellectual property to the other party. For certain jointly developed works, the parties have agreed to follow an invention allocation procedure to determine ownership. In addition, GF possesses the exclusive right to manufacture the Company’s discrete and embedded STT-MRAM devices developed pursuant to the agreement until the earlier of three years after the qualification of the MRAM device for a particular technology node or four years after the completion of the relevant statement of work under which the device was developed. For the same exclusivity period associated with the relevant device, GF agreed not to license intellectual property developed in connection with the JDA to named competitors of the Company.
Generally, unless otherwise specified in the agreement or a statement of work, the Company and GF share project costs, which do not include personnel or production qualification costs, equally under the JDA. If GF manufactures, sells or transfers to customers wafers containing production quantified STT-MRAM devices that utilize certain design information, GF will be required to pay the Company a royalty. The term of the agreement is four years and is extended until the completion of any development work, if later.
As of March 31, 2018 and December 31, 2017, $0 and $25,000 was receivable from GF, respectively. As of March 31, 2018 and December 31, 2017, $2.9 million and $749,000, respectively, were payable to GF for the Company’s share of the project costs under the JDA. The Company incurred project costs, recognized as research and development expense, of $2.1 million and $1.9 million for the three months ended March 31, 2018 and 2017 respectively. The Company entered into a Statement of Work #4B (the SOW 4B) under the JDA with GF effective August 31, 2016. Under SOW 4B, the Company will collaborate with GF in planning, designing and supporting evaluation of 22nm embedded MRAM arrays. The Company was eligible to receive three substantive milestone payments from this collaboration: (a) $569,000 was due upon the delivery of the Company’s database of bias system schematics; (b) $650,000 was due upon the delivery of a Graphic Design Database System package; and (c) $406,000 is due upon demonstration that the embedded MRAM array meets the specifications agreed upon by the two parties. The milestones were achieved during the year ended December 31, 2017. The Company recognized revenue of $0 and $569,000 from GF in the three months ended March 31, 2018 and 2017, respectively.
On October 21, 2014, GF participated, along with other investors, in the Company’s Series B redeemable convertible preferred stock financing and purchased 192,307 shares at $26.00 per share. Contemporaneously, the Company sold 461,538 shares of its common stock to GF at a discounted price of $0.00026 per share. The common shares vest upon the achievement of a goal as set forth in the Statement of Work #1 (the SOW) under the JDA. The unvested common shares are subject to repurchase by the Company, if the JDA is terminated for any reason, for a one-year period after such termination, at a price that is the lower of the original price paid by GF or the fair value of the Company’s common stock as of the date of repurchase. The Company has determined that the issuance of these shares of common stock to GF represents compensation for services to be provided under the JDA. Accordingly, the shares are accounted for similar to a stock award granted to a non-employee of the Company and are remeasured to their fair value as they vest. Although the shares issued do not commence vesting until the achievement of the product qualification (the “Initial Measurement Date”), the Company has deemed it probable that the qualification requirement will be met and compensation expense related to the shares issued is being recognized prior to the Initial Measurement Date. Due to the vesting conditions, there will be multiple measurement dates, occurring on the Initial Measurement Date and at the end
18
of each month thereafter. The fair value of vesting shares is effectively fixed at each measurement date while the fair value of the remaining unvested shares will be remeasured each subsequent measurement date until the shares are fully vested. During the year ended December 31, 2016, GF achieved the product qualification as set forth under the SOW. As such, a total of 211,538 shares of common stock became vested on August 21, 2016, the designated Initial Measurement Date. Subsequent to the Initial Measurement Date through March 31, 2018, an additional 182,692 shares of common stock became vested. As of March 31, 2018, there were 67,307 shares unvested that were subject to repurchase.
The Company recognized non-cash compensation expense of $237,000 and $255,000 during the three months ended March 31, 2018 and 2017, respectively, in research and development expense related to the vesting of the shares of common stock. The Company recognizes compensation expense based on the estimated fair value of the common stock at each reporting period, which was $7.55 and $7.50 per share as of March 31, 2018 and December 31, 2017, respectively.
Transactions with NXP
The Company has entered into various transactions with NXP, a related party due to its equity ownership in the Company. The Company leases its manufacturing facility in Chandler, Arizona, from NXP and total rent expense was $327,000 and $289,000 during the three months ended March 31, 2018 and 2017, respectively. NXP also performs processing of the Company’s products in its facility which are capitalized as part of the cost of inventory. The total processing costs incurred by the Company were $864,000 and $427,000 for the three months ended March 31, 2018 and 2017, respectively. In addition, NXP is one of the Company’s largest customers for the sale of backend foundry services, and total revenue from NXP was $482,000 and $572,000 during the three months ended March 31, 2018 and 2017, respectively. In the three months ended March 31, 2018 and 2017, the Company purchased wafers for its Condor product from NXP for $157,000 and $168,000, respectively. There was $652,000 and $638,000 of wafers purchased from NXP for the Company’s Condor product included in inventory as of March 31, 2018 and December 31, 2017, respectively. Amounts due from NXP were $382,000 and $587,000 at March 31, 2018 and December 31, 2017, respectively. Amounts due to NXP were $821,000 and $945,000 at March 31, 2018 and December 31, 2017, respectively.
9. Net Loss Per Common Share
The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share amounts):
|
|
Three Months Ended |
|
||||
|
|
March 31, |
|
||||
|
|
2018 |
|
2017 |
|
||
Numerator: |
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,277) |
|
$ |
(6,086) |
|
Denominator: |
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
14,872,369 |
|
|
12,498,698 |
|
Less: weighted-average unvested common shares subjected to repurchase |
|
|
(83,333) |
|
|
(198,717) |
|
Weighted-average common shares outstanding used to calculate net loss per common share, basic and diluted |
|
|
14,789,036 |
|
|
12,299,981 |
|
Net loss per common share, basic and diluted |
|
$ |
(0.09) |
|
$ |
(0.49) |
|
The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per common share for the periods presented, because their inclusion would be anti-dilutive:
|
|
Three Months Ended |
|
||
|
|
March 31, |
|
||
|
|
2018 |
|
2017 |
|
Options to purchase common stock |
|
1,766,959 |
|
1,481,632 |
|
Restricted stock units |
|
66,630 |
|
— |
|
Common stock subject to repurchase |
|
67,307 |
|
182,692 |
|
Common stock warrants |
|
27,690 |
|
27,690 |
|
Total |
|
1,928,586 |
|
1,692,014 |
|
19
10. License Agreements
In March 2018, the Company entered into a global cross-license agreement with a customer pursuant to which the Company granted a worldwide, non-exclusive, non-transferable, irrevocable, royalty-bearing license under the Company’s patents to use, sell, import and export the Company’s products. Under the cross-license agreement, the Company received a non-refundable license fee and is entitled to quarterly royalty payments based upon low single digits of the average selling price of products covered under the license agreement. The license was transferred to the customer and the Company recognized the non-refundable license fee during the three months ended March 31, 2018. The cross-license agreement will remain in effect until the licensed patents have expired, been abandoned, or ruled invalid.
20
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
You should read the following discussion and analysis of our financial condition and results of operations together with our condensed financial statements and related notes included in Part I, Item 1 of this report and with our audited financial statements and related notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2017.
Forward-Looking Statements
This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are identified by words such as “believe,” “will,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “could,” “potentially” or the negative of these terms or similar expressions. You should read these statements carefully because they discuss future expectations, contain projections of future results of operations or financial condition, or state other “forward-looking” information. These statements relate to our future plans, strategies, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in this report in Part II, Item 1A — “Risk Factors,” and elsewhere in this report. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. These statements, like all statements in this report, speak only as of their date, and we undertake no obligation to update or revise these statements in light of future developments. We caution investors that our business and financial performance are subject to substantial risks and uncertainties.
Overview
We are the leading provider of MRAM solutions. Our MRAM solutions offer the persistence of non-volatile memory, a type of memory that retains information even in the absence of power, with the speed and endurance of random access memory (RAM). This enables the protection of mission critical data particularly in the event of power interruption or failure. Our MRAM solutions allow our customers in the industrial, automotive, transportation, and enterprise storage markets to design high performance, power efficient and reliable systems without the need for bulky batteries or capacitors.
We derive our revenue from the sale of MRAM-based products in discrete unit form, the sale of services, licenses of and royalties on our MRAM and magnetic sensor technology.
We work directly with our distributors and customers to have our MRAM devices designed into and qualified for their products. Although we maintain direct sales, support, and development relationships with our customers, once our products are designed into a customer’s product, we sell a majority of our products to those customers through distributors. We generated 55% and 78% for the three months ended March 31, 2018 and 2017, respectively, of our revenue from products sold through distributors.
We maintain a direct selling relationship, for strategic purposes, with several key customer accounts. Our sales team and representatives are organized into three primary regions: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific and Japan (APJ). We recognize revenue by geography based on the region in which our products are sold, and not to where the end products in which they are assembled are shipped. Our revenue by region for the periods indicated was as follows (in thousands):
|